Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
83,427 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| Aug 2, 2026 | CGS Administrators | Automated Detection and Quantification of Brain MRIsLCD · CGS-J15-L40223 | Metadata changed |
|---|
| Aug 2, 2026 | CGS Administrators | MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated SteatohepatitisLCD · CGS-J15-L40199 | Codes changed |
|---|
| Aug 2, 2026 | CGS Administrators | MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated SteatohepatitisLCD · CGS-J15-L40199 | New policy |
|---|
| Aug 2, 2026 | CGS Administrators | MolDX: Biomarker Testing for Risk Stratification in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated SteatohepatitisLCD · CGS-J15-L40198 | Metadata changed |
|---|
| Aug 2, 2026 | CGS Administrators | Fluid Jet System in the Treatment of Benign Prostatic Hyperplasia (BPH)LCD · CGS-J15-L40183 | Metadata changed |
|---|
| Aug 2, 2026 | CGS Administrators | Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC)LCD · CGS-J15-L40179 | Metadata changed |
|---|
| Aug 2, 2026 | CGS Administrators | Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC)LCD · CGS-J15-L40178 | Metadata changed |
|---|
| Aug 2, 2026 | CGS Administrators | MolDX: Molecular Testing for Solid Organ Allograft RejectionLCD · CGS-J15-L40140 | Codes changed |
|---|
| Aug 2, 2026 | CGS Administrators | MolDX: Molecular Testing for Solid Organ Allograft RejectionLCD · CGS-J15-L40140 | New policy |
|---|
| Aug 2, 2026 | CGS Administrators | MolDX: Molecular Testing for Solid Organ Allograft RejectionLCD · CGS-J15-L40139 | Metadata changed |
|---|
| Aug 2, 2026 | CGS Administrators | Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT)LCD · CGS-J15-L40056 | Metadata changed |
|---|
| Aug 2, 2026 | CGS Administrators | MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative NeoplasmsLCD · CGS-J15-L40000 | Metadata changed |
|---|
| Aug 2, 2026 | CGS Administrators | Intervertebral Disc RepairLCD · CGS-J15-L39958 | Metadata changed |
|---|
| Aug 2, 2026 | CGS Administrators | MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin AmyloidosisLCD · CGS-J15-L39940 | Metadata changed |
|---|
| Aug 2, 2026 | CGS Administrators | MolDX: Genetic Testing for Heritable Thoracic Aortic DiseaseLCD · CGS-J15-L39938 | Metadata changed |
|---|
| Aug 2, 2026 | CGS Administrators | Botulinum Toxin InjectionsLCD · CGS-J15-L39857 | Metadata changed |
|---|
| Aug 2, 2026 | CGS Administrators | Botulinum Toxin InjectionsLCD · CGS-J15-L39856 | Metadata changed |
|---|
| Aug 2, 2026 | CGS Administrators | Artificial Intelligence Enabled CT Based Quantitative Coronary Topography (AI-QCT)/Coronary Plaque Analysis (AI-CPA)LCD · CGS-J15-L39840 | Metadata changed |
|---|
| Aug 2, 2026 | CGS Administrators | Minimally Invasive Arthrodesis of the Sacroiliac Joint (SIJ)LCD · CGS-J15-L39802 | Metadata changed |
|---|
| Aug 2, 2026 | CGS Administrators | Cervical FusionLCD · CGS-J15-L39741 | Metadata changed |
|---|
| Aug 2, 2026 | CGS Administrators | MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following BronchoscopyLCD · CGS-J15-L39658 | Metadata changed |
|---|
| Aug 2, 2026 | CGS Administrators | Trigger Point Injections (TPI)LCD · CGS-J15-L39656 | Metadata changed |
|---|
| Aug 2, 2026 | CGS Administrators | MolDX: Molecular Testing for Risk Stratification of Thyroid NodulesLCD · CGS-J15-L39650 | Metadata changed |
|---|
| Aug 2, 2026 | CGS Administrators | MolDX: Gene Expression Profile Tests for Decision-Making in Castration Resistant and Metastatic Prostate CancersLCD · CGS-J15-L39648 | Metadata changed |
|---|
| Aug 2, 2026 | CGS Administrators | Urinary Biomarkers for Chronic Pain ManagementLCD · CGS-J15-L39616 | Metadata changed |
|---|
| Aug 2, 2026 | CGS Administrators | MolDX: Molecular Biomarker Testing for Risk Stratification of Cutaneous Squamous Cell CarcinomaLCD · CGS-J15-L39585 | Metadata changed |
|---|
| Aug 2, 2026 | CGS Administrators | Amniotic and Placental Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-WoundLCD · CGS-J15-L39575 | Metadata changed |
|---|
| Aug 2, 2026 | CGS Administrators | Positron Emission Tomography (PET) Scan for Inflammation and InfectionLCD · CGS-J15-L39521 | Metadata changed |
|---|
| Aug 2, 2026 | CGS Administrators | Cosmetic and Reconstructive SurgeryLCD · CGS-J15-L39506 | Metadata changed |
|---|
| Aug 2, 2026 | CGS Administrators | Allogeneic Hematopoietic Cell Transplantation for Primary Refractory or Relapsed Hodgkin's and Non-Hodgkin's Lymphoma with B-cell or T-cell OriginLCD · CGS-J15-L39434 | Metadata changed |
|---|
| Aug 2, 2026 | CGS Administrators | MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid ArthritisLCD · CGS-J15-L39427 | Metadata changed |
|---|
| Aug 2, 2026 | CGS Administrators | MolDX: Molecular Assays for the Diagnosis of Cutaneous MelanomaLCD · CGS-J15-L39389 | Metadata changed |
|---|
| Aug 2, 2026 | CGS Administrators | Sacroiliac Joint Injections and ProceduresLCD · CGS-J15-L39383 | Metadata changed |
|---|
| Aug 2, 2026 | CGS Administrators | Prostate Cancer Detection with IsoPSA®LCD · CGS-J15-L39284 | Metadata changed |
|---|
| Aug 2, 2026 | CGS Administrators | MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and NeoplasiaLCD · CGS-J15-L39276 | Metadata changed |
|---|
| Aug 2, 2026 | CGS Administrators | MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification TestingLCD · CGS-J15-L39038 | Codes changed |
|---|
| Aug 2, 2026 | CGS Administrators | MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification TestingLCD · CGS-J15-L39038 | Metadata changed |
|---|
| Aug 2, 2026 | CGS Administrators | Platelet Rich Plasma Injections for Non-Wound InjectionsLCD · CGS-J15-L39023 | Metadata changed |
|---|
| Aug 2, 2026 | CGS Administrators | MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with CancerLCD · CGS-J15-L39017 | Metadata changed |
|---|
| Aug 2, 2026 | CGS Administrators | Epidural Steroid Injections for Pain ManagementLCD · CGS-J15-L39015 | Metadata changed |
|---|
| Aug 2, 2026 | CGS Administrators | MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate CancerLCD · CGS-J15-L38997 | Codes changed |
|---|
| Aug 2, 2026 | CGS Administrators | MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate CancerLCD · CGS-J15-L38997 | Metadata changed |
|---|
| Aug 2, 2026 | CGS Administrators | Electroretinography (ERG)LCD · CGS-J15-L38992 | Metadata changed |
|---|
| Aug 2, 2026 | CGS Administrators | Off-label Use of Rituximab and Rituximab BiosimilarsLCD · CGS-J15-L38920 | Codes changed |
|---|
| Aug 2, 2026 | CGS Administrators | Off-label Use of Rituximab and Rituximab BiosimilarsLCD · CGS-J15-L38920 | Metadata changed |
|---|
| Aug 2, 2026 | CGS Administrators | MolDX: Minimal Residual Disease Testing for CancerLCD · CGS-J15-L38822 | Metadata changed |
|---|
| Aug 2, 2026 | CGS Administrators | Colon Capsule Endoscopy (CCE)LCD · CGS-J15-L38777 | Metadata changed |
|---|
| Aug 2, 2026 | CGS Administrators | Facet Joint Interventions for Pain ManagementLCD · CGS-J15-L38773 | Metadata changed |
|---|
| Aug 2, 2026 | CGS Administrators | Non-Invasive Fractional Flow Reserve (FFR) for Ischemic Heart DiseaseLCD · CGS-J15-L38771 | Metadata changed |
|---|
| Aug 2, 2026 | CGS Administrators | Computed Tomography Cerebral Perfusion Analysis (CTP)LCD · CGS-J15-L38694 | Metadata changed |
|---|